Founded by a dentist Dr. Yi SeungGyu in 2009, Domo Bio is a company specializing in snoring and obstructive sleep apnea device, called QT33. QT33 has obtained patent in Korea, US and China. The device is currently being actively supplied in Korea and the company plans to expand to the US market as soon as it obtains US FDA approval.

Domo Bio’s QT33 is not just a simple improvement on the function and user convenience aspect; It is a completely new snoring and obstructive sleep apnea device. QT33 only requires two sessions without any surgery or pain to complete the treatment, and allows comfortable jaw movement thanks to its upper/lower separation structure and personalized system. So far, more than 97% of the patients using the device have expressed high level of satisfaction and have experienced dramatic improvement in snoring and sleep apnea.

Domo Bio’s mission is to provide solution for snoring and sleep apnea so that people can lead a healthier and happier life, breaking away from the fear aroused from snoring and sleep apnea. Domo Bio plans to devote itself to supplying QT33 and continuing research & development.